Anifrolumab (Saphnelo) in PEI

April 23, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in PEI effective April 23, 2024.

For more information, please visit the PEI Pharmacare Program website.

Lupus Blog Articles:

Lupus and Heart Health: Understanding Cardiovascular Risk in SLE

Read

OCT Screening Hydroxychloroquine Coverage | Lupus Canada Advocacy

Read

The Lupus Canada Annual General Meeting 2026

Read